Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data - Mease, P; Charles-Schoeman, C; Cohen, S (Ann Rheum Dis, 2020)